Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Retained Earnings (2022 - 2025)

Historic Retained Earnings for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$256.9 million.

  • PAVmed's Retained Earnings changed N/A to -$256.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$256.9 million, marking a year-over-year change of. This contributed to the annual value of -$255.0 million for FY2024, which is 1340.47% up from last year.
  • As of Q3 2025, PAVmed's Retained Earnings stood at -$256.9 million.
  • PAVmed's Retained Earnings' 5-year high stood at -$155.8 million during Q1 2022, with a 5-year trough of -$320.6 million in Q2 2024.
  • Its 4-year average for Retained Earnings is -$248.8 million, with a median of -$252.8 million in 2024.
  • As far as peak fluctuations go, PAVmed's Retained Earnings crashed by 5795.55% in 2023, and later skyrocketed by 2339.35% in 2025.
  • Quarter analysis of 4 years shows PAVmed's Retained Earnings stood at -$228.2 million in 2022, then fell by 29.04% to -$294.4 million in 2023, then rose by 13.4% to -$255.0 million in 2024, then decreased by 0.76% to -$256.9 million in 2025.
  • Its Retained Earnings was -$256.9 million in Q3 2025, compared to -$250.6 million in Q2 2025 and -$237.3 million in Q1 2025.